SEC Form 4 · accession 0001638599-17-000676
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Milton Boyer
Officer — SVP, Drug Product Manufacturin
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2017 | F | 1,619 | $21.72 | D | 37,867 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.